CVU 10 月早鸟报名即将截止！
提前注册我们的年度临床疫苗学更新 (CVU) 10 月 28 日星期五 即将关门！
我们的面对面活动将通过主题演讲和互动分组会议提供专业发展，以及与同行交流和交流的机会。
立即注册，不要错过这个机会，聆听顶尖专家介绍免疫领域的最新发展和趋势。
要查看该计划并注册，请单击下面的链接进入我们的活动页面。
AusVaxSafety 提供世界首个 JYNNEOS 猴痘疫苗的实时安全数据
新发布的 AusVaxSafety 对 1,300 多剂 JYNNEOS® 首剂疫苗的监测数据显示，54% 疫苗接种者在疫苗接种后的前 7 天内没有出现任何副作用。在报告症状的疫苗接种者中，副作用通常是轻微且短暂的，包括局部反应、疲劳、头痛和肌肉/关节疼痛。
为了提供有关在澳大利亚使用 JYNNEOS® 的进一步指导，AusVaxSafety 将继续收集和发布这些信息，包括第 2 剂后的副作用。
要阅读完整更新，请单击下面的链接。
全球首个 JYNNEOS 猴痘疫苗的实时安全数据可从 AusVax安全
加入 MVEC 免疫技能研讨会的候补名单 – 2022 年 11 月 25 日星期五
Registrations for MVEC’s Immunisation Skills Workshop taking place on Friday 25日 November are now at capacity! If you missed out on registering for the session, we invite you to join our waitlist by emailing [email protected], and should a spot become available we will contact you to register.
The full-day interactive, face-to-face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing:
- 有效的疫苗沟通
- 错误预防和管理
- 过敏反应和急性应激反应。
Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios.
For more information, please click on the link below to our events page.
MVEC: Immunisation Skills Workshop
8 月 30 日 CVU mini 的录音现已发布
Thank you to all who attended our recent CVU miniseries event COVID-19：6 个月及以上儿童的感染和疫苗 on Tuesday 30th August 2022.
This interactive webinar provided an update on:
- 6 个月以上儿童感染 COVID-19：墨尔本的经验
- 针对 6 个月以上澳大利亚儿童的 COVID-19 疫苗建议
- 儿童 COVID-19 疫苗的安全性
A recording of this event is now available via our education portal.
To access this recording please follow the link below:
2022 年临床疫苗学更新 (CVU) 现已开放注册！
Registrations are now open for the annual Clinical Vaccinology Update (CVU), taking place in person on Friday 28th October.
我们的面对面活动将通过主题演讲和互动分组会议提供专业发展，以及与同行交流和交流的机会。
立即注册，不要错过这个机会，聆听顶尖专家介绍免疫领域的最新发展和趋势。
To find out more about the program and to register, please click on the link below to our Events page.
MVEC：临床疫苗学更新 (CVU) 2022
ATAGI 关于 12-17 岁青少年使用 Novavax 疫苗的建议
ATAGI have now recommended that adolescents aged 12-17 years can receive the Novavax COVID-19 vaccine for their primary course of COVID-19 vaccination. This recommendation provides another vaccine brand option, in addition to Pfizer and Moderna, for individuals in this age group.
A Novavax primary schedule consists of 2 doses, administered 8 weeks apart. Those with 严重的免疫功能低下 should receive 3 doses.
Whilst Novavax is not currently registered for use as a booster dose in adolescents aged 12-17 years, ATAGI advises that it may be used for this purpose, when Pfizer is not suitable for that person.
To read the recommendations in full please follow the link below.
ATAGI recommendations on the use of the Novavax vaccine for adolescents aged 12-17 years.
疫苗工作 GAVI：过去和现在有关猴痘的五张图表
Despite the first cases of monkeypox infection in humans being reported in the 1970’s, previous outbreaks of disease have been relatively small compared with the international outbreak we are currently experiencing. Human to human transmission has been historically uncommon with cases limited to smaller geographical regions. Current rates of infection, with extensive human to human transmission and wide global spread has led this outbreak to be a very unique scenario.
The following article uses the latest data to explore the current rates of infection across different demographics and regions, the impact of pre-existing medical conditions, as well as vaccine access and severity of disease.
To read the article in full, click on the link below.
疫苗工作 GAVI：过去和现在有关猴痘的五张图表
To view our reference page on monkeypox, click on the link below.
MVEC：猴痘
VACSIG 网络研讨会录音现已提供
A webinar recording is now available from the recent Vaccination Special Interest Group (VACSIG) event on Wednesday 17 August. The topic for the webinar was Monkeypox & smallpox vaccines: an Australian perspective, and featured a panel of expert speakers including MVEC’s A/Prof Nigel Crawford.
To view the recording, please click on the link below.
VACSIG Webinar 17 August
MVEC 免疫技能研讨会现已开放报名 – 2022 年 11 月 25 日星期五
MVEC are pleased to announce that registrations for our 免疫技能研讨会 taking place on Friday 25日 November are now open.
The full day interactive, face to face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing:
- 有效的疫苗沟通
- 错误预防和管理
- 过敏反应和急性应激反应。
Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios.
The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time).
地点： The HELP Precinct, The HELP Precinct, 皇家儿童医院, 50 Flemington Road, Parkville
时间： 上午 8:30 至下午 4:30
成本： $290.00（含餐饮）
Register for the Immunisation Skills Workshop now via the link below!
MVEC Immunisation Skills Workshop
八月 CVU 迷你活动现已开放报名
MVEC’s next Clinical Vaccinology Update (CVU) mini event on COVID-19: infection and vaccines in children aged 6 months and over will take place virtually on Tuesday 30th August. This CVU mini will provide an update on:
- 针对 6 个月以上澳大利亚儿童的 COVID-19 疫苗建议
- 儿童 COVID-19 疫苗的安全性
- COVID-19 vaccine rollout logistics
The event program and link to register will be available shortly via our Events page or via the link below.